Curaleaf Holdings (CURLF) Minority Interest (2019 - 2024)
Curaleaf Holdings (CURLF) posted quarterly Minority Interest of $125.7 million for Q3 2024, up 5.41% year-on-year from $119.3 million in Q4 2023, and up 9.98% on a QoQ basis from $114.3 million in Q2 2024.
Curaleaf Holdings (CURLF) Minority Interest (2019 - 2024) Analysis & Trends
Curaleaf Holdings (CURLF) has reported Minority Interest for 6 consecutive years, with $125.7 million the latest figure, recorded in Q3 2024.
- Quarterly Minority Interest rose 5.41% year-over-year to $125.7 million in Q3 2024, while the trailing twelve-month figure through Sep 2024 was $125.7 million (up 5.41% YoY) and the FY2023 annual result came in at $120.6 million, changed N/A from the prior year.
- Minority Interest climbed to $125.7 million in Q3 2024 per CURLF's latest filing, from $114.3 million in the prior quarter.
- Over the last five years, Minority Interest for CURLF reached as high as $116.8 billion in Q1 2022 and fell as low as $1.9 million in Q3 2020.
- A 5-year average of $7.9 billion and a median of $119.3 million in 2023 frame the typical range for Minority Interest.
- The largest YoY upside for Minority Interest was 5579880.89% in 2022 against a maximum downside of 13.98% in 2022.
- Year by year, Minority Interest stood at $2.1 million in 2020, then surged by 5584.28% to $119.0 million in 2021, then advanced by 1.8% to $121.1 million in 2022, then slipped by 0.38% to $120.6 million in 2023, then climbed by 4.22% to $125.7 million in 2024.
- According to Business Quant data, Minority Interest over the past three periods registered $125.7 million, $114.3 million, and $120.6 million for Q3 2024, Q2 2024, and Q4 2023 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Curaleaf Holdings | 7.13 Bn | 7.13 Bn | 157.29 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2024 | 125.74 Mn |
| Jun 30, 2024 | 114.33 Mn |
| Dec 31, 2023 | 120.65 Mn |
| Sep 30, 2023 | 119.29 Mn |
| Jun 30, 2023 | 123.30 Mn |
| Dec 31, 2022 | 121.11 Mn |
| Sep 30, 2022 | 118.02 Mn |
| Jun 30, 2022 | 112.14 Mn |
| Mar 31, 2022 | 116.79 Bn |
| Dec 31, 2021 | 118.97 Mn |
| Sep 30, 2021 | 125.91 Mn |
| Jun 30, 2021 | 130.37 Mn |
| Mar 31, 2021 | 2.09 Mn |
| Dec 31, 2020 | 2.09 Mn |
| Sep 30, 2020 | 1.93 Mn |
| Dec 31, 2019 | -2.62 Mn |